Home› Uterine/Endometrial Cancer

Article about new treatment protocol

Forherself
Forherself CSN Member Posts: 1,039
August 2024 in Uterine/Endometrial Cancer #1

https://www.medscape.com/viewarticle/fda-expands-dostarlimab-gxly-approval-endometrial-cancer-2024a1000eaa?ecd=mkm_ret_240818_mscpmrk_onc_gyno_etid6753926&uac=389007SR&impID=6753926

It's always nice to see a new article about endometrial cancer.

1

Comments

  • NoTimeForCancer
    NoTimeForCancer CSN Member Posts: 3,572
    August 2024 #2

    Thank you, Forherself. The RUBY trial had a lot of significant findings. I certainly pray there are some answers.

    0

Discussion Boards

  • All Discussion Boards
  • 6 CSN Information
  • 6 Welcome to CSN
  • 122.3K Cancer specific
  • 2.8K Anal Cancer
  • 451 Bladder Cancer
  • 310 Bone Cancers
  • 1.6K Brain Cancer
  • 28.5K Breast Cancer
  • 399 Childhood Cancers
  • 27.9K Colorectal Cancer
  • 4.6K Esophageal Cancer
  • 1.2K Gynecological Cancers (other than ovarian and uterine)
  • 13K Head and Neck Cancer
  • 6.4K Kidney Cancer
  • 678 Leukemia
  • 799 Liver Cancer
  • 4.2K Lung Cancer
  • 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
  • 240 Multiple Myeloma
  • 7.2K Ovarian Cancer
  • 66 Pancreatic Cancer
  • 493 Peritoneal Cancer
  • 5.6K Prostate Cancer
  • 1.2K Rare and Other Cancers
  • 544 Sarcoma
  • 740 Skin Cancer
  • 659 Stomach Cancer
  • 192 Testicular Cancer
  • 1.5K Thyroid Cancer
  • 5.9K Uterine/Endometrial Cancer
  • 6.3K Lifestyle Discussion Boards